AMPLE
2017
Australasian Malignant Pleural Effusion Trial
In 146 patients with symptomatic malignant pleural effusion, indwelling pleural catheter reduced hospital days during the first year compared with talc pleurodesis.
Result
Primary endpoint: Hospital days within 1 year
IPC vs talc median 10 vs 12 hospital days (p=0.03); effusion-related days 1 vs 4 (p<.001); re-intervention 4.1% vs 22.5% (p=.001); QoL similar.
- Subtopic
- Malignant effusion
- Design
- Multicentre open-label RCT, Australia/NZ/Singapore/Hong Kong (9 centres)
- Relevance
- Supporting: context rather than must-know.
- Cited in
- BTS 2023 Pleural Disease
- Source
- Thomas R, et al. JAMA. 2017;318(19):1903-1912.doi 10.1001/jama.2017.17426
Discussion & critique
IPC is non-inferior for symptom control and reduces hospitalisation versus talc pleurodesis.